Quick Takeaways
- Iroquois Capital Management, LLC filed SCHEDULE 13G/A for Clearmind Medicine Inc. Common Stock, no par value (CMND).
- Disclosed ownership: 6.2%.
- Date of event: 31 Dec 2024.
Iroquois Capital Management, LLC - 31 Dec 2024 SCHEDULE 13G/A Report for Clearmind Medicine Inc. Common Stock, no par value (CMND)
- Filing Manager
- Iroquois Capital Management, LLC
- Reporting Manager
- Richard Abbe
- Symbol
- CMND
- Shares outstanding
- 7,238,542 shares
- Disclosed Ownership
- 451,685 shares
- Ownership
- 6.2%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Feb 2025, 13:27:27 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 18 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Iroquois Capital Management, LLC disclosed 6.2% ownership in Clearmind Medicine Inc. Common Stock, no par value (CMND) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Feb 2025, 13:27.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Iroquois Capital Management, LLC | 5% | 250,267 | 0 | 250,267 | /s/ Richard Abbe | Richard Abbe, President | |
| Richard Abbe | 6.2% | 451,685 | 201,418 | 250,267 | /s/ Richard Abbe | Richard Abbe | |
| Kimberly Page | 5% | 250,267 | 0 | 250,267 | /s/ Kimberly Page | Kimberly Page |